• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (65)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Women's Health  • Women's Health, Other  • Randomized Controlled Trial  • Alert me on articles by topic  Social Bookmarking   What's this?

Jae Hee Kang, ScD; Nancy Cook, ScD; JoAnn Manson, MD, DrPH; Julie E. Buring, ScD; Francine Grodstein, ScD

Arch Intern Med. 2006;166:2462-2468.

Background  Oxidative stress may play a key role in the development of cognitive impairment. Long-term supplementation with vitamin E, a strong antioxidant, may provide cognitive benefits.

Methods  The Women's Health Study is a randomized, double-blind, placebo-controlled trial of vitamin E supplementation (600 IU [-tocopherol acetate], on alternate days) begun between 1992 and 1995 among 39 876 healthy US women. From 1998, 6377 women 65 years or older participated in a cognitive substudy. Three cognitive assessments of general cognition, verbal memory, and category fluency were administered by telephone at 2-year intervals. The primary outcome was a global composite score averaging performance on all tests. Repeated measures analyses were conducted to examine mean performance and mean differences in cognitive change, and logistic regression was used to estimate relative risks of substantial decline.

Results  There were no differences in global score between the vitamin E and placebo groups at the first assessment (5.6 years after randomization: mean difference, –0.01; 95% confidence interval [CI], –0.04 to 0.03) or at the last assessment (9.6 years of treatment: mean difference, 0.00; 95% CI, –0.04 to 0.04). Mean cognitive change over time was also similar in the vitamin E group compared with the placebo group for the global score (mean difference in change, 0.02; 95% CI, –0.01 to 0.05; P = .16). The relative risk of substantial decline in the global score in the vitamin E group compared with the placebo group was 0.92 (95% CI, 0.77 to 1.10).

Conclusion  Long-term use of vitamin E supplements did not provide cognitive benefits among generally healthy older women.

Author Affiliations: Channing Laboratory (Drs Kang, Manson, and Grodstein) and Division of Preventive Medicine (Drs Cook, Manson, and Buring), Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, and Department of Epidemiology, Harvard School of Public Health (Drs Manson, Buring, and Grodstein), Boston, Mass.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Preventing Cognitive Decline in Usual Aging
Mark A. Espeland and Victor W. Henderson
Arch Intern Med. 2006;166(22):2433-2434.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging
Bowman et al.
Neurology 2012;78:241-249.
ABSTRACT | FULL TEXT  

French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial
Kesse-Guyot et al.
Am J Clin Nutr 2011;94:892-899.
ABSTRACT | FULL TEXT  

A Potential Design Flaw of Randomized Trials of Vitamin Supplements
Morris and Tangney
JAMA 2011;305:1348-1349.
FULL TEXT  

Total antioxidant capacity of diet in relation to cognitive function and decline
Devore et al.
Am J Clin Nutr 2010;92:1157-1164.
ABSTRACT | FULL TEXT  

Systematic Review: Factors Associated With Risk for and Possible Prevention of Cognitive Decline in Later Life
Plassman et al.
ANN INTERN MED 2010;153:182-193.
ABSTRACT | FULL TEXT  

Promising Strategies for the Prevention of Dementia
Middleton and Yaffe
Arch Neurol 2009;66:1210-1215.
ABSTRACT | FULL TEXT  

Ten-Year Change in Plasma Amyloid {beta} Levels and Late-Life Cognitive Decline
Okereke et al.
Arch Neurol 2009;66:1247-1253.
ABSTRACT | FULL TEXT  

Vitamin E, Vitamin C, Beta Carotene, and Cognitive Function Among Women With or at Risk of Cardiovascular Disease: The Women's Antioxidant and Cardiovascular Study
Kang et al.
Circulation 2009;119:2772-2780.
ABSTRACT | FULL TEXT  

Dementia Prevention: Methodological Explanations for Inconsistent Results
Coley et al.
Epidemiol Rev 2008;30:35-66.
ABSTRACT | FULL TEXT  

Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort
Ravaglia et al.
Am J Clin Nutr 2008;87:1306-1313.
ABSTRACT | FULL TEXT  

Antioxidants and Prevention of Cognitive Decline: Does Duration of Use Matter?
Yaffe
Arch Intern Med 2007;167:2167-2168.
FULL TEXT  

A Randomized Trial of Beta Carotene Supplementation and Cognitive Function in Men: The Physicians' Health Study II
Grodstein et al.
Arch Intern Med 2007;167:2184-2190.
ABSTRACT | FULL TEXT  

Low dose aspirin and cognitive function in the women's health study cognitive cohort
Kang et al.
BMJ 2007;334:987-987.
ABSTRACT | FULL TEXT  

Vitamin E and Cognitive Function in Women
JWatch Neurology 2007;2007:3-3.
FULL TEXT  

Childhood intelligence and being a vegetarian
Richards
BMJ 2007;334:216-217.
FULL TEXT  

Vitamin E Supplementation Fails to Prevent Cognitive Decline
JWatch General 2007;2007:5-5.
FULL TEXT  

Preventing Cognitive Decline in Usual Aging
Espeland and Henderson
Arch Intern Med 2006;166:2433-2434.
FULL TEXT